Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Brain scans and imaging

Topic: Brain proteins, microglia and lab models

Plain-language summary

The purpose of this meta-analysis was to determine the common signature of dysregulated brain glucose metabolism in late-onset age-associated neurodegenerative diseases (A2NDs), including Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis. FDG-PET studies published through July 2025 were identified from MEDLINE, Embase, PsycINFO, Scopus, and Cochrane databases. Studies comparing adults with late-onset neurodegenerative disease to healthy controls and reporting whole-brain coordinate findings were included. Activation likelihood estimation meta-analyses were conducted using extracted coordinates of hypo- and hypermetabolism. A total of 130 studies were included, comprising 5,298 individuals with A2ND and 3,499 controls. Meta-analyses revealed dysregulated glucose metabolism as a unifying feature across A2NDs and included both hypo- and hypermetabolic patterns. However, the spatial distribution of metabolic abnormalities differed across diseases, with each disease demonstrating distinct neuroanatomical patterns associated with disease-relevant functional systems. While hypometabolism primarily in the cortex remains a primary focus in neurodegenerative disease research due to functional relevance, hypermetabolism was also consistently identified across all three diseases, predominantly in subcortical, limbic, and cerebellar structures. This dissociation, with hypermetabolic regions localized to structures with known functional connectivity to affected cortical networks, suggests compensatory upregulation as a plausible interpretation, though alternative mechanisms, including neuroinflammation, cannot be excluded.

What this study adds

Evidence grade: High

This is a pooled review of 5,298 participants. This meta-analysis found that altered brain glucose metabolism is a shared feature across Alzheimer's, Parkinson's and ALS, but each disease shows its own distinct spatial pattern of metabolic change. It does not test any treatment, cure or prevention, so it offers no direct implications for those goals.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Raikes, A. C., Garza, M., Tirambulo, C. V. G., Murrell, A. N., & Brinton, R. D. (2026). Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures. medRxiv (preprint). https://doi.org/10.64898/2026.04.07.26350339

Vancouver

Raikes AC, Garza M, Tirambulo CVG, Murrell AN, Brinton RD. Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures. medRxiv (preprint). 2026. doi:10.64898/2026.04.07.26350339.

BibTeX

@article{raikes2026-16df6f75,
  author  = {Raikes, A. C. and Garza, M. and Tirambulo, C. V. G. and Murrell, A. N. and Brinton, R. D.},
  title   = {{Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.04.07.26350339},
  url     = {https://doi.org/10.64898/2026.04.07.26350339}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This meta-analysis found that altered brain glucose metabolism is a shared feature across Alzheimer's, Parkinson's and ALS, but each disease shows its own distinct spatial pattern of metabolic change. It does not test any treatment, cure or prevention, so it offers no direct implications for those goals.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 42 of the 94 points it could be judged on, which is 45 of 100. Raw total 45 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 45 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 45 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 42 of the 94 points we could judge it on, which is 45 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 5,298 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Roberta Dı́az Brinton: h-index 88 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Arizona: institution h-index 1,336 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 42 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 42 of the 94 points we could judge it on is 45 out of 100.
Total 45 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Brain scans and imaging from nearby years

Also tagged “precursor”

1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →